Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

enoxolone, hyaluronic acid, levomenol, telmesteine, vitis vinifera drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
enoxolone, hyaluronic acid, levomenol, telmesteine, vitis vinifera drug combination
Unique ID
C515552
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C515552
Entry Term(s)
MAS 065D
MAS-065D
MAS065D
XCLAIR
enoxolone - hyaluronic acid - levomenol - telmesteine - vitis vinifera
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Glycyrrhetinic Acid
*Hyaluronic Acid
Frequency
2
Note
also contains vitis vinifera, shea butter, telmestine, and bisabolol; may be of benefit in treating radiation-induced dermatitis
Source
Cutan Ocul Toxicol 2006;25(3):165-71
Date of Entry
2006/12/16
Revision Date
2014/10/27
enoxolone, hyaluronic acid, levomenol, telmesteine, vitis vinifera drug combination Preferred
XCLAIR Narrower
MAS 065D Narrower
page delivered in 0.004s